<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11693">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552513</url>
  </required_header>
  <id_info>
    <org_study_id>FRN: MCT-79654</org_study_id>
    <secondary_id>ISRCTN20993046</secondary_id>
    <nct_id>NCT00552513</nct_id>
  </id_info>
  <brief_title>Early Versus Delayed Timing of Intervention in Patients With Acute Coronary Syndromes</brief_title>
  <acronym>TIMACS</acronym>
  <official_title>An International Randomised Trial of Early Versus Delayed Invasive Strategies in Patients With Non-ST Segment Elevation Acute Coronary Syndromes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <authority>Canada: Canadian Institutes of Health Research</authority>
    <authority>Canada: Ethics Review Committee</authority>
    <authority>Australia: Human Research Ethics Committee</authority>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <authority>Belgium: Institutional Review Board</authority>
    <authority>Colombia: Institutional Review Board</authority>
    <authority>Czech Republic: Ethics Committee</authority>
    <authority>India: Institutional Review Board</authority>
    <authority>Romania: National Medicines Agency</authority>
    <authority>Thailand: Ethical Committee</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The timing of intervention study is a prospective, randomized, international, multicentre
      comparison of the relative efficacy, safety, and cost effectiveness of a management strategy
      of coronary angiography and intervention performed within 24 hours of randomization versus
      delayed coronary angiography and intervention in patients after 36 hours with acute coronary
      syndromes (ACS).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Composite of Death, Myocardial (re-) Infarction, or Stroke</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>First Occurrence of Any Component of the Composite of Death, MI, or Refractory Ischemia</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of Death, MI, Stroke, Refractory Ischemia or Repeat Revascularization at 180 Days</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke at 30 Days and 180 Days</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Mechanical or Pharmacological Coronary Revascularization (i.e. Thrombolysis, PCI, CABG) at Days 30, 90, and 180</measure>
    <time_frame>180 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital Major Bleeding</measure>
    <time_frame>Hospital discharge</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3031</enrollment>
  <condition>Unstable Angina</condition>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Early Coronary Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) as soon as possible (within 24 hours of randomisation).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Coronary Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Delayed intervention: Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) any time after 36 hours after randomisation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early Coronary Intervention</intervention_name>
    <description>Perform coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) as soon as possible (and within 24 hours of randomisation).</description>
    <arm_group_label>Early Coronary Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Delayed Coronary Intervention</intervention_name>
    <description>Perform coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) any time after 36 hours after randomisation.</description>
    <arm_group_label>Delayed Coronary Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients presenting or admitted to hospital with symptoms suspected to represent an
             acute coronary syndrome (unstable angina or MI without persistent ST elevation) i.e.,
             clinical history consistent with new onset, or a worsening pattern, of characteristic
             ischemic chest pain or ischemic symptoms occurring at rest or with minimal activity
             (lasting longer than five minutes or requiring sublingual nitroglycerin for relief of
             the pain)

          2. Able to randomise within 24 hours of the onset of the most recent episode of symptoms

          3. At least two of the three following additional criteria:

               -  Age more than or equal to 60 years

               -  Troponin T or I or Creatine Kinase - Myocardial Bands (CK-MB) above the upper
                  limit of normal for the local institution

               -  ElectroCardioGram (ECG) changes compatible with ischemia (i.e., ST depression at
                  least 1 mm in two contiguous leads or T wave inversion mroe than 3 mm or any
                  dynamic ST shift or transient ST elevation)

          4. Written informed consent dated and signed

        Exclusion Criteria:

          1. Age less than 21 years

          2. Not a suitable candidate for revascularisation

          3. Co-morbid condition with life expectancy less than six months
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shamir Mehta, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute, Hamilton Health Sciences, McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.phri.ca</url>
    <description>Population Health Research Institute</description>
  </link>
  <reference>
    <citation>MICHELANGELO OASIS 5 Steering Committee, Mehta SR, Yusuf S, Granger CB, Wallentin L, Peters RJ, Bassand JP, Budaj A, Joyner C, Chrolavicius S, Fox KA. Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2005 Dec;150(6):1107.</citation>
    <PMID>16338245</PMID>
  </reference>
  <results_reference>
    <citation>Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009 May 21;360(21):2165-75. doi: 10.1056/NEJMoa0807986.</citation>
    <PMID>19458363</PMID>
  </results_reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>October 30, 2007</firstreceived_date>
  <firstreceived_results_date>May 27, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>timing</keyword>
  <keyword>intervention</keyword>
  <keyword>early</keyword>
  <keyword>delayed</keyword>
  <keyword>acute coronary syndromes</keyword>
  <keyword>PCI</keyword>
  <keyword>angiography</keyword>
  <keyword>Non ST-segment elevation myocardial infarction</keyword>
  <keyword>unstable angina</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Early</title>
          <description>Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) as soon as possible (within 24 hours of randomisation).</description>
        </group>
        <group group_id="P2">
          <title>Delayed</title>
          <description>Delayed intervention: Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) any time after 36 hours after randomisation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1593"/>
                <participants group_id="P2" count="1438"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1588"/>
                <participants group_id="P2" count="1437"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Early</title>
          <description>Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) as soon as possible (within 24 hours of randomisation).</description>
        </group>
        <group group_id="B2">
          <title>Delayed</title>
          <description>Delayed intervention: Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) any time after 36 hours after randomisation.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="1593"/>
                <measurement group_id="B2" value="1438"/>
                <measurement group_id="B3" value="3031"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <sub_title>Age</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="65.1" spread="0"/>
                <measurement group_id="B2" value="65.8" spread="0"/>
                <measurement group_id="B3" value="65.5" spread="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="554"/>
                <measurement group_id="B2" value="498"/>
                <measurement group_id="B3" value="1052"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1039"/>
                <measurement group_id="B2" value="940"/>
                <measurement group_id="B3" value="1979"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite of Death, Myocardial (re-) Infarction, or Stroke</title>
        <time_frame>180 days</time_frame>
        <safety_issue>No</safety_issue>
        <population>All patients were included in the final intention-to-treat analysis. Event rates in the two groups were estimated with the use of the Kaplan–Meier method. The hazard ratio and two-sided 95% confidence intervals were calculated with the use of a Cox proportional-hazards model.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Intervention</title>
            <description>Coronary angiography to be performed as rapidly as possible and within 24 hours after randomization</description>
          </group>
          <group group_id="O2">
            <title>Delayed Intervention</title>
            <description>Coronary angiography to be performed after a minimum delay of 36 hours after randomization</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1593"/>
                  <measurement group_id="O2" value="1438"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Composite of Death, Myocardial (re-) Infarction, or Stroke</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="153" lower_limit="0.68" upper_limit="1.06"/>
                  <measurement group_id="O2" value="163" lower_limit="0.68" upper_limit="1.06"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.15</p_value>
            <method>Regression, Logistic</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.68</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Occurrence of Any Component of the Composite of Death, MI, or Refractory Ischemia</title>
        <time_frame>180 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Early Intervention</title>
          </group>
          <group group_id="O2">
            <title>Delayed Intervention</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1593"/>
                  <measurement group_id="O2" value="1438"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>First Occurrence of Any Component of the Composite of Death, MI, or Refractory Ischemia</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="151"/>
                  <measurement group_id="O2" value="186"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.003</p_value>
            <method>Regression, Logistic</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.58</ci_lower_limit>
            <ci_upper_limit>0.89</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Death, MI, Stroke, Refractory Ischemia or Repeat Revascularization at 180 Days</title>
        <time_frame>180 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Early Intervention</title>
          </group>
          <group group_id="O2">
            <title>Delayed Intervention</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1593"/>
                  <measurement group_id="O2" value="1438"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Composite of Death, MI, Stroke, Refractory Ischemia or Repeat Revascularization at 180 Days</title>
            <units>Eparticipants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="264"/>
                  <measurement group_id="O2" value="280"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.04</p_value>
            <method>Regression, Logistic</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke at 30 Days and 180 Days</title>
        <time_frame>180 days</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Need for Mechanical or Pharmacological Coronary Revascularization (i.e. Thrombolysis, PCI, CABG) at Days 30, 90, and 180</title>
        <time_frame>180 days</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>In-hospital Major Bleeding</title>
        <time_frame>Hospital discharge</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Early</title>
          <description>Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) as soon as possible (within 24 hours of randomisation).</description>
        </group>
        <group group_id="E2">
          <title>Delayed</title>
          <description>Delayed intervention: Coronary angiography and intervention (either percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG] surgery) any time after 36 hours after randomisation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PHRI agreements may vary with individual investigators, but will not prohibit any investigator from publishing. PHRI supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>TIMACS Project Office</name_or_title>
      <organization>Population Health Research Institute</organization>
      <phone>19055244322</phone>
      <email>timacs@phri.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
